These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 37315250)
21. [Improvement of the efficacy of treatment of hypertensive encephalohathy by using mexidol]. Bolotova EV; Lushpay NY; Kovrigina IV Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(4):61-64. PubMed ID: 29863694 [TBL] [Abstract][Full Text] [Related]
22. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy]. Abramenko IuV Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676 [TBL] [Abstract][Full Text] [Related]
23. [Asthenic post-COVID syndrome]. Khaibullina DK; Maksimov YN Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3):61-69. PubMed ID: 36946399 [TBL] [Abstract][Full Text] [Related]
24. [Post-COVID-19 asthenic syndrome]. Zolotovskaia IA; Shatskaia PR; Davydkin IL; Shavlovskaya OA Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(4):25-30. PubMed ID: 34037351 [TBL] [Abstract][Full Text] [Related]
25. [Results of a multicentre double-blind randomised placebo-controlled clinical trial evaluating the efficacy and safety of Mexidol in the treatment of Attention Deficit Hyperactivity Disorder in Children (MEGA)]. Zavadenko NN; Suvorinova NY; Batysheva TT; Bykova OV; Platonova AN; Gaynetdinova DD; Levitina EV; Mashin VV; Vakula IN; Maximova NE Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(4):75-86. PubMed ID: 35485068 [TBL] [Abstract][Full Text] [Related]
26. [The system stress-limiting action of mexidol in chronic cerebral ischemia]. Antipenko EA; Derugina AV; Gustov AV Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(4):28-31. PubMed ID: 27240044 [TBL] [Abstract][Full Text] [Related]
27. [Results of clinical studies of the efficacy and safety of the use of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia]. Zhuravleva MV; Kamchatnov PR; Vasyukova NS; Arkhipov VV; Kuznetsova EV; Kameneva TR; Serebrova SY Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):29-39. PubMed ID: 36440774 [TBL] [Abstract][Full Text] [Related]
28. [Chronic cerebrovascular diseases associated with metabolic syndrome: new treatment approaches]. Tanashian MM; Lagoda OV; Antonova KV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11):21-6. PubMed ID: 23257741 [TBL] [Abstract][Full Text] [Related]
29. [Experience with mexidol in neurological practice]. Gromova OA; Torshin IY; Stakhovskaya LV; Pepelyaev EG; Semenov VA; Nazarenko AG Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):97-107. PubMed ID: 30499505 [TBL] [Abstract][Full Text] [Related]
30. [Mono- and combination therapy with the mexidol in young patients with cerebral angiodystonia]. Dyakonova EN; Makerova VV Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8):52-60. PubMed ID: 30251978 [TBL] [Abstract][Full Text] [Related]
31. [The use of neurotropic therapy in young patients with postcovid syndrome]. Ivonina NA; Petrov KB Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):126-130. PubMed ID: 35394732 [TBL] [Abstract][Full Text] [Related]
32. [Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia]. Zhuravleva MV; Prokofiev AB; Serebrova SY; Vasyukova NS; Demchenkova EY; Arkhipov VV Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(6):119-124. PubMed ID: 32678558 [TBL] [Abstract][Full Text] [Related]
33. [Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX]. Putilina MV; Mutovina ZY; Kurushina OV; Khalilova DM; Saverskaya EN; Stepanova SB; Khoreva MA; Starikov AS Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(1):84-90. PubMed ID: 35175707 [TBL] [Abstract][Full Text] [Related]
34. [Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)]. Stakhovskaya LV; Shamalov NA; Khasanova DR; Melnikova EV; Agafiina AS; Golikov KV; Bogdanov EI; Yakupova AA; Roshkovskaya LV; Lukinykh LV; Lokshtanova TM; Poverennova IE; Shepankevich LA Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3. Vyp. 2):55-65. PubMed ID: 28665371 [TBL] [Abstract][Full Text] [Related]
35. [Neurological manifestations of postcovid syndrome]. Kamchatnov PR; Cheremin RA; Skipetrova LA; Chugunov AV Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):7-15. PubMed ID: 35394713 [TBL] [Abstract][Full Text] [Related]
36. [The efficacy of mexidol in carotid endarterectomy procedure in patients with cerebral atherosclerotic stenosis]. Golovkin VI; Svetlikov AV; Shapovalov AS; Popova LO Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(1):51-55. PubMed ID: 26977626 [TBL] [Abstract][Full Text] [Related]
37. [Hypoxia and oxidative stress in cerebral circulation insufficiency - effective ways of correction]. Chukanova EI; Chukanova AS; Rodionova DM Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8):35-40. PubMed ID: 36036401 [TBL] [Abstract][Full Text] [Related]
38. [The role of oxidative stress in hemorrhagic stroke and restorative effects of Mexidol]. Voronina TA; Kraineva VA; Zolotov NN; Kotel'nikova SO; Val'dman EA Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8. Vyp. 2):65-71. PubMed ID: 36036146 [TBL] [Abstract][Full Text] [Related]
39. [An experience with neuroprotective therapy of primary open-angle glaucoma based on the use of different dosage forms of Mexidol]. Leonova ES; Polyakov SV; Pozdnyakova МА; Yarygina ЕP; Semisynov SО Vestn Oftalmol; 2015; 131(6):91-94. PubMed ID: 26977733 [TBL] [Abstract][Full Text] [Related]